A critical discovery in cancer study is arising with the use of nanobodies to reactivate dysfunctional p53. This vital malignant suppressor protein is frequently inactivated in many forms of malignancies, leading https://socialeweb.com/story7457027/mini-antibodies-reactivate-the-p53-protein-the-potential-pathway-for-malignant-management